References
- Rasmussen-Torvik LJ, Li M, Kao W et al. Association of a fasting glucose genetic risk score with subclinical atherosclerosis: the Atherosclerosis Risk in Communities (ARIC) study. Diabetes60(1), 331–335 (2010).
- Rasmussen-Torvik LJ, Alonso A, Li M et al. Impact of repeated measures and sample selection on genome-wide association studies of fasting glucose. Genet. Epidemiol.34(7), 665–673 (2010).
- Arking DE, Chakravarti A. Understanding cardiovascular disease through the lens of genome-wide association studies. Trends Genet.25(9), 387–394 (2009).
- Janssens AC, Aulchenko YS, Elefante S, Borsboom GJ, Steyerberg EW, van Duijn CM. Predictive testing for complex diseases using multiple genes: fact or fiction? Genet. Med.8(7), 395–400 (2006).
- Janssens AC, Moonesinghe R, Yang Q, Steyerberg EW, van Duijn CM, Khoury MJ. The impact of genotype frequencies on the clinical validity of genomic profiling for predicting common chronic diseases. Genet. Med.9(8), 528–535 (2007).
- Wray NR, Goddard ME, Visscher PM. Prediction of individual genetic risk to disease from genome-wide association studies. Genome Res.17(10), 1520–1528 (2007).
- The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators. Am. J. Epidemiol.129(4), 687–702 (1989).
- Dupuis J, Langenberg C, Prokopenko I et al. New genetic loci implicated in fasting glucose homeostasis and their impact on Type 2 diabetes risk. Nat. Genet.42(2), 105–116 (2010).
- Lango H, Palmer CN, Morris AD et al. Assessing the combined impact of 18 common genetic variants of modest effect sizes on Type 2 diabetes risk. Diabetes57(11), 3129–3135 (2008).
- Chasman DI, Paré G, Zee RY et al. Genetic loci associated with plasma concentration of low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, triglycerides, apolipoprotein A1, and apolipoprotein B among 6382 white women in genome-wide analysis with replication. Circ. Cardiovasc. Genet.1(1), 21–30 (2008).
- Chasman DI, Paré G, Mora S et al. Forty-three loci associated with plasma lipoprotein size, concentration, and cholesterol content in genome-wide analysis. PLoS Genet.5(11), e1000730 (2009).
- Liu S, Song Y. Building genetic scores to predict risk of complex diseases in humans: is it possible? Diabetes59(11), 2729–2731 (2010).
- Martinelli N, Trabetti E, Pinotti M et al. Combined effect of hemostatic gene polymorphisms and the risk of myocardial infarction in patients with advanced coronary atherosclerosis. PLoS One3(2), e1523 (2008).
- Weedon MN, McCarthy MI, Hitman G et al. Combining information from common Type 2 diabetes risk polymorphisms improves disease prediction. PLoS Med.3(10), e374 (2006).
- Palmer CN, Kimber CH, Doney AS et al. Combined effect of inflammatory gene polymorphisms and the risk of ischemic stroke in a prospective cohort of subjects with Type 2 diabetes: a Go-DARTS study. Diabetes59(11), 2945–2948 (2010).
- van Hoek M, Dehghan A, Witteman JC et al. Predicting Type 2 diabetes based on polymorphisms from genome-wide association studies: a population-based study. Diabetes57(11), 3122–3128 (2008).
- Talmud PJ, Hingorani AD, Cooper JA et al. Utility of genetic and non-genetic risk factors in prediction of Type 2 diabetes: Whitehall II prospective cohort study. BMJ340, b4838 (2010).